Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice

Endocrinology

Volumn 145, Issue 8, 2004, Pages 3866-3872

  Henriques, Tracy A ^a   Huang, Jing ^a   D'Souza, Susan S ^a   Daugherty, Alan ^a,b   Cassis, Lisa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; APOLIPOPROTEIN E; ESTROGEN; RENIN; SEX HORMONE;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SPLEEN; TISSUE LEVEL; VASCULAR DISEASE;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; FEMALE; GONADAL STEROID HORMONES; MALE; MICE; MICE, INBRED C57BL; ORCHIECTOMY; OVARIECTOMY; SEX CHARACTERISTICS;

EID: 3843150433     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1615     Document Type: Article

References (50)

1. Leinwand LA 2003 Sex is a potent modifier of the cardiovascular system. J Clin Invest 112:302-307
2. Rodin MB, Daviglus ML, Wong GC, Liu K, Garside DB, Greenland P, Stamler J 2003 Middle age cardiovascular risk factors and abdominal aortic aneurysm in older age. Hypertension 42:61-65
3. Blanchard JF, Armenian HK, Friesen PP 2000 Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 151:575-583
4. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153
5. Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi QL, Smith S, MooreCox A, Bosch J, Riley WA, Teo KK 2001 Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103:919-925
6. -/- mice. Ann NY Acad Sci 892:108-118
7. Daugherty A, Manning MW, Cassis LA 2000 Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605-1612
8. Weiss D, Kools JJ, Taylor WR 2001 Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation 103:448-454
9. Wang YX, Martin McNulty B, Freay AD, Sukovich DA, Halks Miller M, Li WW, Vergona R, Sullivan ME, Morser J, Dole WP, Deng GG 2001 Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 159:1455-1464
10. Manning MW, Cassis LA, Huang J, Szilvassy SJ, Daugherty A 2002 Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 7:45-54
11. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
12. Tse J, Martin-McNaulty B, Halks Miller M, Kauser K, Del Vecchio V, Vergona R, Sullivan ME, Rubanyi GM 1999 Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17β-estradiol. Atherosclerosis 144:303-313
13. Bjarnason NH, Haarbo J, Byrjalsen I, Alexandersen P, Kauffman RF, Christiansen C 2001 Raloxifene and estrogen reduces progression of advanced atherosclerosis: a study in ovariectomized, cholesterol-fed rabbits. Atherosclerosis 154:97-102
14. Marsh MM, Walker VR, Curtiss LK, Banka CL 1999 Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 40:893-900
15. Elhage R, Amal JF, Pieraggi MT, Duverger N, Fievet C, Faye JC, Bayard F 1997 17β-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 17:2679-2684
16. Bourassa PAK, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ 1996 Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 93:10022-10027
17. Martin McNulty B, Tham DM, daCunha V, Ho JJ, Wilson DW, Rutledge JC, Deng GG, Vergona R, Sullivan ME, Wang YX 2003 17β-Estradiol attenuates development of angiotensin II induced aortic abdominal aneurysm in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 23:1627-1632
18. Liu PY, Death AK, Handelsman DJ 2003 Androgens and cardiovascular disease. Endocr Rev 24:313-340
19. Rockhold RW 1993 Cardiovascular toxicity of anabolic steroids. Annu Rev Pharmacol Toxicol 33:497-520
20. Melchert RB, Welder AA 1995 Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 27:1252-1262
21. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ 1998 The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1-15
22. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C 1999 Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819
23. Nathan L, Shi WB, Dinh H, Mukherjee TK, Wang XP, Lusis AJ, Chaudhuri G 2001 Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98:3589-3593
24. Mukherjee TK, Dinh H, Chaudhuri G, Nathan L 2002 Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci USA 99:4055-4060
25. Daugherty A, Manning MW, Cassis LA 2001 Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 134:865-870
26. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, Colbry N, Dyer RD, Feinmark SJ, Daugherty A 1997 Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 120:1199-1206
27. Shetty G, Weng CC 2004 Cryptorchidism rescues spermatogonial differentiation in juvenile spermatogonial depletion (jsd) mice. Endocrinology 145:126-133
28. Cassis LA, Huang J, Gong MC, Daugherty A 2004 Role of metabolism and receptor responsiveness in the attenuated responses to angiotensin II in mice compared to rats. Regul Pept 117:107-116
29. Daugherty A, Whitman SC 2003 Quantification of atherosclerosis in mice. Methods Mol Biol 209:293-309
30. Tangirala RK, Rubin EM, Palinski W 1995 Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36:2320-2328
31. Dansky HM, Charlton SA, Harper MM, Smith JD 1997 T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 94:4642-4646
32. Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH 1998 Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(A). Proc Natl Acad Sci USA 95:4544-4549
33. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, Shu P, Moore KJ, Breslow JL, Smith JD 1999 Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19:1960-1968
34. -/- mice. J Int Cytol Res 22:661-670
35. -/- mice. J Clin Invest 107:333-340
36. Nilsson O, Chrysis D, Pajulo O, Boman A, Holst M, Rubinstein J, Martin Ritzen E, Savendahl L 2003 Localization of estrogen receptors-α and -β and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol 177:319-326
37. McDougall KE, Perry MJ, Gibson RL, Colley SM, Korach KS, Tobias JH 2003 Estrogen receptor-α dependency of estrogen's stimulatory action on cancellous bone formation in male mice. Endocrinology 144:1994-1999
38. Foreman MD 1986 Cardiovascular disease. A men's health hazard. Nurs Clin North Am 21:65-73
39. Kalin MF, Zumoff B 1990 Sex hormones and coronary disease: a review of the clinical studies. Steroids 55:330-352
40. von Dehn G, von Dehn O, Volker W, Langer C, Weinbauer GF, Behre HM, Nieschlag E, Assmann G, von Eckardstein A 2001 Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res 33:110-114
41. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ 1994 Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 79:561-567
42. Phillips GB, Pinkernell BH, Jing TY 1994 The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 14:701-706
43. Khaw KT, Barrett-Connor E 1991 Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb 11:489-494
44. Manning MW, Cassis LA, Daugherty A 2003 Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23:483-488
45. Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang QX, Li B 2003 Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 144:1656-1663
46. Fischer M, Baessler A, Schunkert H 2002 Rerun angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53:672-677
47. Shah PK1997 Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96:2115-2117
48. Reed D, Reed C, Stemmermann G, Hayashi T 1992 Are aortic aneurysms caused by atherosclerosis? Circulation 85:205-211
49. Saraff K, Babamusta F, Cassis LA, Daugherty A 2003 Aortic dissection precedes formation of aneurysms and atherosclerosis in angII-Infused apoE deficient mice. Arterioscler Thromb Vasc Biol 23:1621-1626
50. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, Thinnes T, Loskutoff DJ, Carmeliet P, Dole WP, Wang YX 2003 Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 92:510-517